SynDRA canonical compound SYN0038551 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Primary target(s) | BTK | EGFR | ITK | JAK3 |
| Mechanism of action | Bruton's tyrosine kinase (BTK) inhibitor | EGFR inhibitor |
| Indication | non-small cell lung cancer (NSCLC) |
| Disease area | oncology |